In a report released today, Travis Steed from Bank of America Securities maintained a Buy rating on Medtronic (MDT – Research Report).

In a report released today, Matt Miksic from Barclays reiterated a Buy rating on Medtronic (MDT – Research Report), with a price target ...

The lawsuit, filed Tuesday in U.S. District Court in Delaware, is the latest in a series of patent challenges against ...

Dr. Shirin Towfigh claims the medical device giant “knowingly copied” her design for a hernia device treatment.

Medtronic and Recor Medical each announced separate Medicare reimbursement approvals for their respective renal denervation ...

The pulse oximeter, a device that measures the degree to which red blood cells are saturated with oxygen, is one of healthcare's most fundamental tools.

NeurAxis (NASDAQ:NRXS – Get Free Report) and Medtronic (NYSE:MDT – Get Free Report) are both medical companies, but which is the superior stock? We will compare the two companies based on the strength ...

The latest trading day saw Medtronic (MDT) settling at $87.72, representing a -0.45% change from its previous close.

Patient and physician education is the next challenge to change the treatment paradigm for drug-resistant hypertension, Citi Research analyst Joanne Wuensch said.

Ping An Healthcare and Technology Company Limited ("Ping An Good Doctor", "Ping An Health", or "the Company", Stock Code: ...

Roots Community Health has sued 12 other firms, including GE Healthcare, CVS and Walgreens, and called for manufacturers and ...